Annual Operating Expenses
$166.55 M
-$105.21 M-38.72%
December 31, 2023
Summary
- As of February 8, 2025, AKBA annual total operating expenses is $166.55 million, with the most recent change of -$105.21 million (-38.72%) on December 31, 2023.
- During the last 3 years, AKBA annual operating expenses has fallen by -$209.44 million (-55.70%).
- AKBA annual operating expenses is now -65.01% below its all-time high of $475.95 million, reached on December 31, 2019.
Performance
AKBA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$35.77 M
+$446.00 K+1.26%
September 30, 2024
Summary
- As of February 8, 2025, AKBA quarterly total operating expenses is $35.77 million, with the most recent change of +$446.00 thousand (+1.26%) on September 30, 2024.
- Over the past year, AKBA quarterly operating expenses has increased by +$446.00 thousand (+1.26%).
- AKBA quarterly operating expenses is now -74.85% below its all-time high of $142.24 million, reached on December 31, 2018.
Performance
AKBA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AKBA Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.7% | +1.3% |
| 3 y3 years | -55.7% | -52.5% |
| 5 y5 years | -56.0% | -52.5% |
AKBA Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.8% | at low | -59.7% | +1.3% |
| 5 y | 5-year | -65.0% | at low | -71.7% | +1.3% |
| alltime | all time | -65.0% | +1854.1% | -74.8% | +1288.3% |
Akebia Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $35.77 M(+1.3%) |
| Jun 2024 | - | $35.33 M(-1.5%) |
| Mar 2024 | - | $35.88 M(-0.8%) |
| Dec 2023 | $166.55 M(-38.7%) | $36.16 M(-2.0%) |
| Sep 2023 | - | $36.90 M(-23.4%) |
| Jun 2023 | - | $48.18 M(+6.3%) |
| Mar 2023 | - | $45.31 M(-27.9%) |
| Dec 2022 | $271.76 M(-16.5%) | $62.86 M(+3.6%) |
| Sep 2022 | - | $60.66 M(+2.5%) |
| Jun 2022 | - | $59.16 M(-33.4%) |
| Mar 2022 | - | $88.85 M(+17.9%) |
| Dec 2021 | $325.48 M(-13.4%) | $75.39 M(-14.0%) |
| Sep 2021 | - | $87.70 M(+10.0%) |
| Jun 2021 | - | $79.76 M(-3.5%) |
| Mar 2021 | - | $82.63 M(+4.6%) |
| Dec 2020 | $375.99 M(-21.0%) | $79.02 M(-9.9%) |
| Sep 2020 | - | $87.74 M(-1.8%) |
| Jun 2020 | - | $89.34 M(-25.5%) |
| Mar 2020 | - | $119.89 M(-5.1%) |
| Dec 2019 | $475.95 M(+25.9%) | $126.30 M(+15.2%) |
| Sep 2019 | - | $109.62 M(-10.6%) |
| Jun 2019 | - | $122.66 M(+4.5%) |
| Mar 2019 | - | $117.38 M(-17.5%) |
| Dec 2018 | $378.13 M | $142.24 M(+75.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $81.01 M(-4.1%) |
| Jun 2018 | - | $84.45 M(+19.9%) |
| Mar 2018 | - | $70.43 M(-7.3%) |
| Dec 2017 | $257.90 M(+86.9%) | $75.95 M(+16.0%) |
| Sep 2017 | - | $65.46 M(+29.2%) |
| Jun 2017 | - | $50.66 M(-23.1%) |
| Mar 2017 | - | $65.84 M(+66.3%) |
| Dec 2016 | $138.00 M(+124.3%) | $39.58 M(+9.4%) |
| Sep 2016 | - | $36.18 M(-0.0%) |
| Jun 2016 | - | $36.19 M(+38.9%) |
| Mar 2016 | - | $26.05 M(+29.9%) |
| Dec 2015 | $61.51 M(+62.1%) | $20.05 M(+1.9%) |
| Sep 2015 | - | $19.68 M(+80.7%) |
| Jun 2015 | - | $10.89 M(-0.1%) |
| Mar 2015 | - | $10.90 M(+2.7%) |
| Dec 2014 | $37.94 M(+138.1%) | $10.61 M(+10.7%) |
| Sep 2014 | - | $9.58 M(+22.2%) |
| Jun 2014 | - | $7.84 M(-20.9%) |
| Mar 2014 | - | $9.91 M(+59.8%) |
| Dec 2013 | $15.93 M(+86.9%) | $6.20 M(+53.7%) |
| Sep 2013 | - | $4.03 M(+29.3%) |
| Jun 2013 | - | $3.12 M(+21.1%) |
| Mar 2013 | - | $2.58 M |
| Dec 2012 | $8.52 M | - |
FAQ
- What is Akebia Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Akebia Therapeutics?
- What is Akebia Therapeutics annual operating expenses year-on-year change?
- What is Akebia Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly operating expenses year-on-year change?
What is Akebia Therapeutics annual total operating expenses?
The current annual operating expenses of AKBA is $166.55 M
What is the all time high annual operating expenses for Akebia Therapeutics?
Akebia Therapeutics all-time high annual total operating expenses is $475.95 M
What is Akebia Therapeutics annual operating expenses year-on-year change?
Over the past year, AKBA annual total operating expenses has changed by -$105.21 M (-38.72%)
What is Akebia Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of AKBA is $35.77 M
What is the all time high quarterly operating expenses for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly total operating expenses is $142.24 M
What is Akebia Therapeutics quarterly operating expenses year-on-year change?
Over the past year, AKBA quarterly total operating expenses has changed by +$446.00 K (+1.26%)